Endovascular beta irradiation for prevention of restenosis using solution radioisotopes: Pharmacologic and dosimetric properties of rhenium-188 compounds

Cardiovascular Radiation Medicine

Volumn 1, Issue 1, 1999, Pages 86-97

  Knapp Jr , F F ^a   Guhlke, Stefan ^a   Beets, Arnold L ^a   Lin, Wan Yu ^a   Stabin, Michael ^b   Amols, Howard ^c   Weinberger, Judah ^c  

^a Life Sci Div Oak Ridge Natl L   (United States)

^b OAK RIDGE INSTITUTE FOR SCIENCE AND EDUCATION   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Liquid filled balloons; Radionuclide generator; Restenosis; Rhenium 188

Indexed keywords

IODIDE; OLIGOPEPTIDE; ORGANOMETALLIC COMPOUND; PERCHLORIC ACID; RADIOISOTOPE; RADIOPHARMACEUTICAL AGENT; RHENIUM; RHENIUM MERCAPTOACETYLTRIGLYCINE; RHENIUM-MERCAPTOACETYLTRIGLYCINE; SODIUM DERIVATIVE; SODIUM PERCHLORATE;

ANIMAL; ARTICLE; BETA RADIATION; CORONARY ARTERY DISEASE; DRUG EFFECT; DRUG STABILITY; FISCHER 344 RAT; RADIATION EXPOSURE; RAT; RECURRENT DISEASE; THYROID GLAND; TISSUE DISTRIBUTION; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANIMALS; BETA RAYS; CORONARY DISEASE; DRUG STABILITY; IODIDES; OLIGOPEPTIDES; ORGANOMETALLIC COMPOUNDS; PERCHLORIC ACID; RADIOISOTOPES; RADIOPHARMACEUTICALS; RATS; RATS, INBRED F344; RECURRENCE; RHENIUM; SODIUM COMPOUNDS; THYROID GLAND; TISSUE DISTRIBUTION;

EID: 0032601123     PISSN: 15221865     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1522-1865(98)00009-2     Document Type: Article

References (36)

1. Bottcher H.D., Schopohl B., Lermann D., Kollath J., Adamietz I.A. Endovascular irradiation - a new method to avoid recurrent stenosis after stent implantation in peripheral arteries. technique and preliminary results Int. J. Radiat. Oncol. Biol. Phys. 29:1994;183-186.
2. Wiederman J., Marboe C., Amols H., Schwartz A., Weinberger J. Intracoronary irradiation markedly reduces restenosis after balloon angioplasty in a porcine model. J. Am. Coll. Cardiol. 23:1994;1491-1498.
3. Wiederman J., Marobe C., Amols H., Schwartz A., Weinberger J. Intracoronary irradiation markedly reduces neointimal proliferation after balloon angioplasty in swine. Persistent benefit at 6-month follow-up. J. Am. Coll. Cardiol. 25:1995;1451-1456.
4. Fischell T.A., Kharma B.K., Fischell D.R.et al. Low-dose beta-particle emission from "stent" wire results in complete, localized inhibition of smooth muscle cell proliferation. Circulation. 90:1994;2956-2963.
5. Waksman R., Robinson K.A., Crocker I.R., Gravanis M.B., Cipolla G.D., King S.B. Endovascular low-dose irradiation inhibits neointima formation after coronary artery balloon injury in swine. A possible role for radiation therapy in restenosis prevention. Circulation. 91:1995;1533-1539.
6. Mazur W., Ali M.N., Khan M.M.et al. High dose rate intracoronary radiation for inhibition of neointimal formation in the stented and balloon-injured porcine models of restenosis. angiographic, morphometric and histopathologic analysis Int. J. Radiat. Oncol. Biol. Phys. 36:1996;777-778.
7. Amols H., Zaider M., Weinberger J., Ennis R., Schiff P.B., Reinstein L.E. Dosimetric considerations for catheter-based beta and gamma emitters in the therapy of neointimal hyperplasia in human coronary arteries. Int. J. Radiat. Oncol. Biol. Phys. 36:1996;913-921.
8. Tierstein P.S., Massullo V., Jani S.et al. Catheter-based radiotherapy to inhibit restenosis after coronary stenting. N. Engl. J. Med. 336:1997;1697-1703.
9. Amols H.I., Reinstein L.E., Weinberger J. Dosimetry of a radioactive coronary balloon dilation catheter for treatment of neointimal hyperplasia [abstract]. Med. Phys. 23:1996;1080-1081.
10. Raizner A.E. Endovascular radiation using HDR with beta and gamma sources in the porcine model. Waksman R. Advances in cardiovascular radiation therapy. 1997;99-101 Cardiology Research Foundation, Washington, DC.
11. Smith E.F., Pipes D., Konijnenberg M., Ferguson M.S., Kirkman T. Efficacy of a Re-186-filled PTCA balloon system to prevent restenosis of peripheral vessels in swine and A-V graphs in sheep [abstract]. In. Advances in cardiovascular radiation therapy:1997;Cardiology Research Foundation, Washington, DC.
12. Whiting J.S., Li A.N., Litvack F., Eigler N.L. Comparison of the 3-D dose distributions in the arterial media delivered by P-32 and V-48 stents, Re-188 and Re-186 liquid balloons, and Y-90 seeds using dose-volume histograms based on Monte Carlo simulations [abstract]. Advances in cardiovascular radiation therapy. 1997;Cardiology Research Foundation, Washington, DC.
13. Lederer C.M., Shirley V.S. Table of isotopes. 7th ed:1978;Wiley, New York.
14. Callahan A.P., Rice D.E., McPherson D.W., Mirzadeh S., Knapp F.F. Jr. The use of alumina "SepPaks®" as a simple method for the removal and determination of tungsten-188 breakthrough from tungsten-188/rhenium-188 generators. Appl. Radiat. Isot. 43:1992;801-804.
15. Knapp F.F. Jr., Beets A.L., Guhlke S.et al. Availability of rhenium-188 from the alumina-based tungsten-188/rhenium-188 generator for preparation of rhenium-188-labeled radiopharmaceuticals for cancer therapy. Anticancer Res. 17:1997;1783-1796.
16. Knapp F.F. Jr., Mirzadeh S., Zamora P.et al. Rhenium-188 - cost-effective therapeutic applications of a readily available, generator-derived radioisotope [abstract]. Nucl. Med. Commun. 17:1996;268.
17. Knapp F.F. Jr., Mirzadeh S., Beets A.L.et al. Curie-scale tungsten-188/rhenium-188 generators for routine clinical applications. Nicolini M., Bandoli G., Mazzi U. Technetium and rhenium in chemistry and nuclear medicine (Vol. 4. 1995;319-323 SG Editoriali, Padua, Italy.
18. Knapp F.F. Jr. Rhenium-188 - a generator-derived radioisotope for cancer therapy. Cancer Biotherapy and Radiopharmaceuticals. 13:1998;337-348.
19. Knapp F.F. Jr., Lisic E.C., Mirzadeh S., Callahan A.P., Rice D.E. A new clinical prototype tungsten-188/rhenium-188 generator to provide high levels of carrier-free rhenium-188 for radioimmunotherapy. Schmidt H.A.E., Hoefer R. Nuclear medicine in research and practice. 1992;183-186 Schattauer Verlag, Stuttgart, Germany.
20. Callahan A.P., Rice D.E., Knapp F.F. Jr. Rhenium-188 for therapeutic applications from an alumina-based tungsten-188/rhenium-188 radionuclide generator. NucCompact. 20:1989;3-6.
21. 188Re-pentavalent rhenium dimercaptosuccinic acid complex. Nucl. Med. Commun. 14:1993;197-203.
22. Blower P.J. Extending the life of a Tc-99m-generator. a simple and convenient method for concentrating generator eluate for clinical use Nucl. Med. Comm. 14:1993;995-997.
23. Stabin M.G., Taylor J.R.A., Eshima D., Wooter W. Radiation dosimetry for technetium-99m MAG3, technetium-99m-DTPA, and iodine-131-OIH based on human biodistribution studies. J. Nucl. Med. 33:1992;33-40.
24. Berman M., Braverman L., Burke J.et al. MIRD dose estimate report no. 5. radiation absorbed dose estimates for I-123, I-124, I-125, I-126, I-130, I-131, and I-132 as sodium iodide J. Nucl. Med. 16:1975;857-860.
25. Loevinger R., Budinger T., Watson E. MIRD primer for absorbed dose calculations. 1988;Society of Nuclear Medicine, New York.
26. Stabin M. MIRDOSE - the personal computer software for use in internal dose assessment in nuclear medicine. J. Nucl. Med. 37:1996;538-546.
27. Hayes R.L., Rafter J.J. Rhenium-188 as a possible diagnostic agent [abstract]. J. Nucl. Med. 7:1966;797.
28. Lewis R.E., Eldridge J.S. Production of 70-d tungsten-188 and development of a 17 h rhenium-188 generatror. J. Nucl. Med. 7:1966;804-805.
29. Hayes R.L., Rafter J.J. Rhenium-188 as a possible diagnostic agent. In. Research report:1966;Medical Division, Oak Ridge Associated Universities, Oak Ridge, TN.
30. Hayes R.L. Chemistry and radiochemistry of metal-ion nuclides commonly employed in radiopharmaceuticals. Heindel N.D., Burns H.D., Honda T., Brady L.W. The chemistry of radiopharmaceuticals. 1978;155-168 Masson Publishing Co, New York.
31. Fritzberg A.R., Kasina S., Eshima D.et al. Synthesis and biological evaluation of technetium-99m MAG3 as a Hippuran replacement. J. Nucl. Med. 27:1986;111-116.
32. Vanbilloen H.P., Bormans G.M., DeRoo M.J.et al. Complexes of technetium-99m with tetrapeptides containing one alanyl and three glycyl moieties. Eur. J. Nucl. Med. 22:1995;325-338.
33. Guhlke S., Diekmann D., Zamora P.O., Knapp F.F. Jr., Biersack H.-J. MAG3 p-nitrophenyl ester for Tc-99m and Re-188 labelling of amines and peptides. Nicolini M., Bandoli G., Mazzi U. Technetium and rhenium in chemistry and nuclear medicine (Vol. 4. 1995;363-366 SG Editoriali, Padua, Italy.
34. Kotzerke J., Fenchel S., Guhlman A.et al. Pharmacokientics of Tc-99m-pertechnetate and Re-188-perrhenate after oral application of perchlorate - option of subsequent care using liquid Re-188 in a balloon catheter. Nucl. Med. Commun. 19:1998;795-801.
35. Giedd K.N., Amols H., Marboe C., Knapp F.F. Jr., Weinberger J. Effectiveness of beta emitting liquid-filled perfusion balloon to prevent restenosis [abstract]. Circulation. 96:1997;I-220.
36. Knapp F.F. Jr., Guhlke S., Beets A.L., Amols H., Weinberger J. Intraarterial irradiation with rhenium-188 for inhibition of restenosis after PTCA - strategy and evaluation of Re-188 species for rapid urinary excretion [abstract]. J. Nucl. Med. 38:1997;124.